MORGAN STANLEY - COMPASS THERAPEUTICS INC ownership

COMPASS THERAPEUTICS INC's ticker is CMPX and the CUSIP is 20454B104. A total of 74 filers reported holding COMPASS THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of COMPASS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$124,679
-67.0%
63,289
-46.8%
0.00%
Q2 2023$378,089
-27.8%
118,896
-25.7%
0.00%
Q1 2023$523,409
+61.3%
160,064
+148.2%
0.00%
Q4 2022$324,425
+1522.1%
64,498
+627.0%
0.00%
Q3 2022$20,000
+900.0%
8,872
+1347.3%
0.00%
Q2 2022$2,000
-94.6%
613
-97.7%
0.00%
Q1 2022$37,000
-33.9%
26,977
+54.4%
0.00%
Q4 2021$56,00017,4730.00%
Other shareholders
COMPASS THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Foresite Capital Management V, LLC 1,246,977$2,456,5453.92%
CHI Advisors LLC 2,829,712$5,574,5322.21%
Ally Bridge Group (NY) LLC 914,630$1,801,8212.12%
Monashee Investment Management LLC 1,226,142$2,415,5001.01%
Orbimed Advisors 22,362,850$44,054,8150.94%
Vivo Capital, LLC 3,556,023$7,005,3650.77%
CAXTON CORP 86,773$170,9420.65%
Prosight Management, LP 935,157$1,842,2590.58%
BRAIDWELL LP 5,954,273$11,729,9180.37%
Rock Springs Capital Management LP 5,513,788$10,862,1620.29%
View complete list of COMPASS THERAPEUTICS INC shareholders